Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4925 | HCWB HCW Biologics Inc. - Common Stock | 1.53 USD | -1.92% | -7.83% | -36.51% | +146.77% | 2.81 M USD | ||
| 4928 | MTNB Matinas Biopharma Holdings, Inc. Common Stock | 2.79 USD | +2.57% | +8.14% | +1450.00% | +350.00% | 2.73 M USD | ||
| 4931 | CLDI Calidi Biotherapeutics, Inc. Common Stock | 1.04 USD | +1.96% | -1.89% | -20.61% | +36.84% | 2.69 M USD | ||
| 4933 | CANF Can-Fite Biopharma Ltd American Depositary Shares, each represe | 2.04 USD | -3.77% | -7.27% | -8.11% | -53.21% | 2.67 M USD | ||
| 4935 | XRTX XORTX Therapeutics Inc. - Common Shares | 1.85 USD | +5.71% | +7.56% | -24.49% | +103.30% | 2.58 M USD | ||
| 4936 | ONCO Onconetix, Inc. - Common Stock | 0.65 USD | +8.33% | -12.16% | -20.73% | -14.47% | 2.57 M USD | ||
| 4940 | ELAB PMGC Holdings Inc. - Common Stock | 3.11 USD | -2.51% | -7.16% | -32.68% | +130.37% | 2.52 M USD | ||
| 4942 | BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 USD | -15.62% | -15.25% | -32.98% | +9.88% | 2.41 M USD | ||
| 4948 | SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 1.45 USD | +0.69% | -3.33% | -39.33% | +116.42% | 2.30 M USD | ||
| 4951 | GNPX Genprex, Inc. - Common Stock | 2.75 USD | +4.96% | +7.42% | -18.64% | +47.06% | 2.25 M USD | ||
| 4960 | OGEN Oragenics Inc. Common Stock | 0.48 USD | -4.00% | 0.00% | -5.88% | -23.81% | 2.17 M USD | ||
| 4963 | GOVX GeoVax Labs, Inc. - Common Stock | 0.29 USD | 0.00% | -9.38% | -40.82% | -80.00% | 2.14 M USD | ||
| 4964 | JUNS Jupiter Neurosciences, Inc. - Common Stock | 2.77 USD | -2.46% | +9.06% | -12.06% | +385.96% | 2.13 M USD | ||
| 4970 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 0.78 USD | -7.14% | -13.33% | -48.68% | -70.79% | 1.98 M USD | ||
| 4982 | ARTL Artelo Biosciences, Inc. - Common Stock | 3.37 USD | -1.17% | -12.47% | -43.83% | +180.83% | 1.72 M USD | ||
| 4990 | SPRC SciSparc Ltd. - Ordinary Shares | 4.43 USD | -4.53% | -3.06% | -8.28% | +0.68% | 1.62 M USD | ||
| 4991 | JAGX Jaguar Health, Inc. - Common Stock | 4.53 USD | -9.40% | +8.89% | +1124.32% | +630.65% | 1.56 M USD | ||
| 4993 | CRIS Curis, Inc. - Common Stock | 0.71 USD | -4.05% | -12.35% | -41.32% | -56.17% | 1.48 M USD | ||
| 4998 | IMMP Immutep Limited - American Depositary Shares | 3.84 USD | -6.57% | -14.48% | +966.67% | +85.51% | 1.40 M USD | ||
| 5000 | PPBT Purple Biotech Ltd - American Depositary Shares | 1.44 USD | -1.37% | +1.41% | -22.16% | +148.28% | 1.34 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |